跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
惠菲顺 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Compound Loratadine Sustained-Release Capsules(II)
Approved
化学药品
Compound Loratadine Sustained-Release Capsules(II)
赫力昂(苏州)制药有限公司
🇨🇳 National Medical Products Administration
Approval Date
Nov 12, 2020
Approval ID
7Leaf1ngwAx
Company
赫力昂(苏州)制药有限公司
Type
化学药品
Approval Details
Approval Id
7Leaf1ngwAx
Approval Number
国药准字H20061250
Generic Name
复方氯雷他定缓释胶囊(Ⅱ)
Generic Name En
Compound Loratadine Sustained-Release Capsules(II)
Trade Name
惠菲顺
Drug Type
化学药品
Dosage Form
缓释制剂
Strength
每粒含:氯雷他定10mg和硫酸伪麻黄碱240mg
Reg Date
2020-11-12
Company Name
赫力昂(苏州)制药有限公司
Company Address
江苏省苏州宝带西路4号
Production Company Name
赫力昂(苏州)制药有限公司
Production Company Address
江苏省苏州市宝带西路4号
Company Detail Path
/organization/he-li-ang-su-zhou-zhi-yao-you-xian-gong-si
Production Company Detail Path
/organization/he-li-ang-su-zhou-zhi-yao-you-xian-gong-si
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Nov 12, 2020
Approval ID
7Leaf1ngwAx
Type
化学药品
Back to NMPA Approvals